OncoCyte Corporation (0KCC.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
4.5800-1.0411 (-18.52%)
At close: 5:04PM GMT
| Previous close | 5.6211 |
| Open | 4.6800 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 4.5800 - 4.6800 |
| 52-week range | 4.5800 - 4.6800 |
| Volume | 217 |
| Avg. volume | N/A |
| Market cap | 417.046M |
| Beta (5Y monthly) | 1.95 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.5070 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Did OncoCyte Corporation (NYSEMKT:OCX) Insiders Buy Up More Shares?
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are also...
- Motley Fool
Why Oncocyte Shot 13% Higher Today
Cancer diagnostics specialist Oncocyte (NYSEMKT: OCX) rose at a double-digit pace on Friday on news that it's tapping the stock market for a new round of capital-raising. Oncocyte priced its previously announced underwritten secondary stock issue of 7.78 million shares at $4.50 apiece. If all goes well, this should bring in gross proceeds of roughly $35 million.
- Simply Wall St.
Need To Know: Analysts Are Much More Bullish On OncoCyte Corporation (NYSEMKT:OCX) Revenues
OncoCyte Corporation (NYSEMKT:OCX) shareholders will have a reason to smile today, with the analysts making...
© 2021 Verizon Media. All rights reserved.
